The Kidney in Cardiovascular Disease
Overview
Authors
Affiliations
Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease.
H S, B S A, Moger V, Swamy M Indian Heart J. 2017; 69(1):11-16.
PMID: 28228293 PMC: 5319008. DOI: 10.1016/j.ihj.2016.07.006.
Nerpin E, Ingelsson E, Riserus U, Sundstrom J, Andren B, Jobs E Nephrol Dial Transplant. 2014; 29(11):2069-74.
PMID: 24916339 PMC: 4209878. DOI: 10.1093/ndt/gfu199.
Galle J, Kleophas W, Dellanna F, Schmid V, Forkel C, Dikta G Nephron Extra. 2012; 2(1):104-14.
PMID: 22739963 PMC: 3383235. DOI: 10.1159/000337334.
Bello A, Hemmelgarn B, Lloyd A, James M, Manns B, Klarenbach S Clin J Am Soc Nephrol. 2011; 6(6):1418-26.
PMID: 21527648 PMC: 3109940. DOI: 10.2215/CJN.09741110.
Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease.
Schneider C, Ferrannini E, DeFronzo R, Schernthaner G, Yates J, Erdmann E J Am Soc Nephrol. 2007; 19(1):182-7.
PMID: 18057215 PMC: 2391042. DOI: 10.1681/ASN.2007060678.